Drug intelligence / Profile preview

1-[3-({[(4-amino-5-fluoro-2-methylquinolin-3-yl)methyl]thio}methyl)phenyl]-2,2,2-trifluoroethane-1,1-diol

Development stage
Unknown
Modality
Small Molecules
01

Overview

This compound is a synthetic small molecule belonging to the class of 4-aminoquinolines. It features a quinoline core substituted with amino and fluoro groups and incorporates a trifluoromethylated ethanediol moiety. The presence of fluorine atoms and the quinoline scaffold suggest potential for biological activity—such as enzyme inhibition or receptor modulation—commonly explored in medicinal chemistry for anti-infective or anticancer properties. However, there is no evidence that this compound has been approved for any indication or entered clinical trials. Its mechanism of action remains uncharacterized in public databases[1][2][6].

Other names
1-(3-((((4-amino-5-fluoro-2-methylquinolin-3-YL)methyl)thio)methyl)phenyl)-2,2,2-trifluoroethane-1,1-diol1-[3-(4-amino–5-fluoro–2-méthyl–3–quinoléinyl)methysulfanyl]methyl)phényl]-2,2,2-trifluoréthanediol (French)

Beyond the preview

Go deeper on 1-[3-({[(4-amino-5-fluoro-2-methylquinolin-3-yl)methyl]thio}methyl)phenyl]-2,2,2-trifluoroethane-1,1-diol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 1-[3-({[(4-amino-5-fluoro-2-methylquinolin-3-yl)methyl]thio}methyl)phenyl]-2,2,2-trifluoroethane-1,1-diol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call